Published in Genes Dev on March 01, 2011
SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med (2011) 11.07
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet (2011) 6.43
The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov (2012) 2.51
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood (2011) 2.44
Pre-mRNA splicing in disease and therapeutics. Trends Mol Med (2012) 2.23
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3. Nat Genet (2013) 2.05
The anti-tumor drug E7107 reveals an essential role for SF3b in remodeling U2 snRNP to expose the branch point-binding region. Genes Dev (2011) 1.64
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res (2013) 1.51
New connections between splicing and human disease. Trends Genet (2012) 1.39
Post-transcriptional spliceosomes are retained in nuclear speckles until splicing completion. Nat Commun (2012) 1.35
Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A. Genes Dev (2013) 1.31
Biologic and clinical significance of somatic mutations of SF3B1 in myeloid and lymphoid neoplasms. Blood (2012) 1.29
Co-transcriptional degradation of aberrant pre-mRNA by Xrn2. EMBO J (2012) 1.23
CPEB1 coordinates alternative 3'-UTR formation with translational regulation. Nature (2013) 1.23
Targeting RNA splicing for disease therapy. Wiley Interdiscip Rev RNA (2013) 1.17
Spliceosome assembly is coupled to RNA polymerase II dynamics at the 3' end of human genes. Nat Struct Mol Biol (2011) 1.15
Defects in spliceosomal machinery: a new pathway of leukaemogenesis. Br J Haematol (2012) 1.12
Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Nat Commun (2016) 1.11
The development and application of small molecule modulators of SF3b as therapeutic agents for cancer. Drug Discov Today (2012) 1.10
Kinetic competition during the transcription cycle results in stochastic RNA processing. Elife (2014) 1.08
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells. Mol Cell (2012) 1.05
Oncogenic alternative splicing switches: role in cancer progression and prospects for therapy. Int J Cell Biol (2013) 1.04
Mechanisms of genome instability induced by RNA-processing defects. Trends Genet (2014) 1.04
The zebrafish sf3b1b460 mutant reveals differential requirements for the sf3b1 pre-mRNA processing gene during neural crest development. Int J Dev Biol (2012) 1.03
Genomics-guided discovery of thailanstatins A, B, and C As pre-mRNA splicing inhibitors and antiproliferative agents from Burkholderia thailandensis MSMB43. J Nat Prod (2013) 1.00
Phosphorylation-mediated regulation of alternative splicing in cancer. Int J Cell Biol (2013) 1.00
The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO Rep (2015) 0.99
Live-cell visualization of pre-mRNA splicing with single-molecule sensitivity. Cell Rep (2013) 0.98
Coherence between cellular responses and in vitro splicing inhibition for the anti-tumor drug pladienolide B and its analogs. J Biol Chem (2013) 0.97
Comparative genomics RNAi screen identifies Eftud2 as a novel regulator of innate immunity. Genetics (2013) 0.97
Defective control of pre-messenger RNA splicing in human disease. J Cell Biol (2016) 0.96
Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia (2014) 0.94
Pre-mRNA splicing-modulatory pharmacophores: the total synthesis of herboxidiene, a pladienolide-herboxidiene hybrid analog and related derivatives. ACS Chem Biol (2013) 0.93
Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold. Medchemcomm (2011) 0.91
HIF-driven SF3B1 induces KHK-C to enforce fructolysis and heart disease. Nature (2015) 0.89
Sudemycin E influences alternative splicing and changes chromatin modifications. Nucleic Acids Res (2014) 0.88
Intron definition and a branch site adenosine at nt 385 control RNA splicing of HPV16 E6*I and E7 expression. PLoS One (2012) 0.88
Chemical perturbation of Mcl-1 pre-mRNA splicing to induce apoptosis in cancer cells. ACS Chem Biol (2013) 0.88
Identification of small molecule inhibitors of pre-mRNA splicing. J Biol Chem (2014) 0.87
The genomic landscape of chronic lymphocytic leukemia: clinical implications. BMC Med (2013) 0.87
Incorporating evolutionary information and functional domains for identifying RNA splicing factors in humans. PLoS One (2011) 0.86
Rearrangements within human spliceosomes captured after exon ligation. RNA (2013) 0.86
The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1. Leukemia (2015) 0.85
Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages. RNA (2016) 0.85
Therapeutic targeting of splicing in cancer. Nat Med (2016) 0.85
Splicing-coupled 3' end formation requires a terminal splice acceptor site, but not intron excision. Nucleic Acids Res (2013) 0.84
Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability. Elife (2017) 0.84
U2 snRNP is required for expression of the 3' end of genes. PLoS One (2014) 0.82
Alternative splicing for diseases, cancers, drugs, and databases. ScientificWorldJournal (2013) 0.82
Pre-mRNA splicing is a determinant of nucleosome organization. PLoS One (2013) 0.82
Genotoxic stress inhibits Ewing sarcoma cell growth by modulating alternative pre-mRNA processing of the RNA helicase DHX9. Oncotarget (2015) 0.81
Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing. PLoS Genet (2013) 0.81
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidates. Pharmacol Res Perspect (2015) 0.81
Inhibitors of CLK protein kinases suppress cell growth and induce apoptosis by modulating pre-mRNA splicing. PLoS One (2015) 0.80
Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes. Leukemia (2016) 0.79
Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy. Trends Mol Med (2015) 0.79
The Natural Product N-Palmitoyl-l-leucine Selectively Inhibits Late Assembly of Human Spliceosomes. J Biol Chem (2015) 0.78
Polypyrimidine tract binding protein inhibits IgM pre-mRNA splicing by diverting U2 snRNA base-pairing away from the branch point. RNA (2014) 0.78
smFRET studies of the 'encounter' complexes and subsequent intermediate states that regulate the selectivity of ligand binding. FEBS Lett (2014) 0.78
The in vivo dynamics of TCERG1, a factor that couples transcriptional elongation with splicing. RNA (2016) 0.78
Genome-wide screen identifies novel machineries required for both ciliogenesis and cell cycle arrest upon serum starvation. Biochim Biophys Acta (2016) 0.77
A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex. PLoS One (2014) 0.77
Mechano-regulation of alternative splicing. Curr Genomics (2013) 0.77
Impact of base pair identity 5' to the spliceosomal branch site adenosine on branch site conformation. RNA (2012) 0.77
Modulating splicing with small molecular inhibitors of the spliceosome. Wiley Interdiscip Rev RNA (2016) 0.77
Regulation of toll-like receptor signaling by the SF3a mRNA splicing complex. PLoS Genet (2015) 0.77
Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasets. Mol Genet Genomics (2015) 0.76
The Dengue Virus NS5 Protein Intrudes in the Cellular Spliceosome and Modulates Splicing. PLoS Pathog (2016) 0.76
Structural and mechanistic insights into human splicing factor SF3b complex derived using an integrated approach guided by the cryo-EM density maps. RNA Biol (2016) 0.76
Inhibition of SNW1 association with spliceosomal proteins promotes apoptosis in breast cancer cells. Cancer Med (2014) 0.76
Inhibition of U4 snRNA in human cells causes the stable retention of polyadenylated pre-mRNA in the nucleus. PLoS One (2014) 0.76
Ruthenium-Catalyzed Olefin Metathesis after Tetra-n-butylammonium Fluoride-Mediated Desilylation. Tetrahedron Lett (2012) 0.75
The genetics of uveal melanoma: current insights. Appl Clin Genet (2016) 0.75
Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment. Biomed Res Int (2016) 0.75
Splicing factor gene mutations in hematologic malignancies. Blood (2016) 0.75
Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A. RNA (2016) 0.75
Large-scale analysis of branchpoint usage across species and cell lines. Genome Res (2017) 0.75
The role of splicing factors in deregulation of alternative splicing during oncogenesis and tumor progression. Mol Cell Oncol (2014) 0.75
USP39 Deubiquitinase Is Essential for KRAS Oncogene-driven Cancer. J Biol Chem (2017) 0.75
Vemurafenib-resistant BRAF selects alternative branch points different from its wild-type BRAF in intron 8 for RNA splicing. Cell Biosci (2015) 0.75
Identification of a small molecule inhibitor that stalls splicing at an early step of spliceosome activation. Elife (2017) 0.75
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature (2008) 18.20
The spliceosome: design principles of a dynamic RNP machine. Cell (2009) 12.82
Expansion of the eukaryotic proteome by alternative splicing. Nature (2010) 8.84
Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs. Cell (1986) 8.06
RNA and disease. Cell (2009) 7.98
Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol (2009) 7.11
Cloning and domain structure of the mammalian splicing factor U2AF. Nature (1992) 6.55
Splicing regulation: from a parts list of regulatory elements to an integrated splicing code. RNA (2008) 6.29
Deciphering the splicing code. Nature (2010) 6.27
A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly. Cell (1988) 6.16
The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol (2007) 6.16
Recognition of the TACTAAC box during mRNA splicing in yeast involves base pairing to the U2-like snRNA. Cell (1987) 6.08
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature (2009) 5.48
Structural insights into translational fidelity. Annu Rev Biochem (2005) 4.97
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol (2007) 4.95
Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev (2010) 4.75
An ATP-independent complex commits pre-mRNA to the mammalian spliceosome assembly pathway. Genes Dev (1991) 3.99
Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol (2007) 3.97
Mammalian pre-mRNA branch site selection by U2 snRNP involves base pairing. Genes Dev (1989) 3.95
Interactions of small nuclear RNA's with precursor messenger RNA during in vitro splicing. Science (1992) 3.94
A compensatory base change in human U2 snRNA can suppress a branch site mutation. Genes Dev (1989) 3.79
Functional recognition of the 3' splice site AG by the splicing factor U2AF35. Nature (1999) 3.72
The splicing factor BBP interacts specifically with the pre-mRNA branchpoint sequence UACUAAC. Cell (1997) 3.68
DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell (2009) 3.66
U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature (2010) 3.65
The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci U S A (2010) 3.08
Evidence that sequence-independent binding of highly conserved U2 snRNP proteins upstream of the branch site is required for assembly of spliceosomal complex A. Genes Dev (1996) 3.06
Inhibition of msl-2 splicing by Sex-lethal reveals interaction between U2AF35 and the 3' splice site AG. Nature (1999) 2.87
A functional association between the 5' and 3' splice site is established in the earliest prespliceosome complex (E) in mammals. Genes Dev (1993) 2.83
Both subunits of U2AF recognize the 3' splice site in Caenorhabditis elegans. Nature (1999) 2.65
Branch nucleophile selection in pre-mRNA splicing: evidence for the bulged duplex model. Genes Dev (1994) 2.63
A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol Cell Biol (1998) 2.62
An alternative splicing network links cell-cycle control to apoptosis. Cell (2010) 2.43
RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition. Mol Cell (2008) 2.39
Structural basis for recognition of the intron branch site RNA by splicing factor 1. Science (2001) 2.35
Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev (1998) 2.30
Functional association of U2 snRNP with the ATP-independent spliceosomal complex E. Mol Cell (2000) 2.27
Interaction of mammalian splicing factor SF3a with U2 snRNP and relation of its 60-kD subunit to yeast PRP9. Science (1993) 2.27
Manipulation of alternative splicing by a newly developed inhibitor of Clks. J Biol Chem (2004) 2.26
UACUAAC is the preferred branch site for mammalian mRNA splicing. Proc Natl Acad Sci U S A (1989) 2.22
Presplicing complex formation requires two proteins and U2 snRNP. Genes Dev (1988) 2.21
Targeting of U2AF65 to sites of active splicing in the nucleus. J Cell Biol (1997) 2.21
"Nought may endure but mutability": spliceosome dynamics and the regulation of splicing. Mol Cell (2008) 2.19
Three recognition events at the branch-site adenine. EMBO J (1996) 2.01
Structural basis for the molecular recognition between human splicing factors U2AF65 and SF1/mBBP. Mol Cell (2003) 2.00
A novel U2 and U11/U12 snRNP protein that associates with the pre-mRNA branch site. EMBO J (2001) 1.97
Human branch point consensus sequence is yUnAy. Nucleic Acids Res (2008) 1.94
Repositioning of the reaction intermediate within the catalytic center of the spliceosome. Mol Cell (2006) 1.89
New antitumor substances, FR901463, FR901464 and FR901465. II. Activities against experimental tumors in mice and mechanism of action. J Antibiot (Tokyo) (1996) 1.87
Mammalian U2 snRNP has a sequence-specific RNA-binding activity. Genes Dev (1989) 1.82
The coupling of alternative splicing and nonsense-mediated mRNA decay. Adv Exp Med Biol (2007) 1.77
Correspondence between a mammalian spliceosome component and an essential yeast splicing factor. Science (1993) 1.71
SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA. FASEB J (2006) 1.65
Modified nucleotides at the 5' end of human U2 snRNA are required for spliceosomal E-complex formation. RNA (2004) 1.63
Competition between the ATPase Prp5 and branch region-U2 snRNA pairing modulates the fidelity of spliceosome assembly. Mol Cell (2007) 1.56
A high-throughput screening strategy identifies cardiotonic steroids as alternative splicing modulators. Proc Natl Acad Sci U S A (2008) 1.56
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Proc Natl Acad Sci U S A (2005) 1.45
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc Natl Acad Sci U S A (2006) 1.45
The biflavonoid isoginkgetin is a general inhibitor of Pre-mRNA splicing. J Biol Chem (2008) 1.43
Spliceostatin A inhibits spliceosome assembly subsequent to prespliceosome formation. Nucleic Acids Res (2010) 1.43
The splicing-factor oncoprotein SF2/ASF activates mTORC1. Proc Natl Acad Sci U S A (2008) 1.42
Up-regulation of the proapoptotic caspase 2 splicing isoform by a candidate tumor suppressor, RBM5. Proc Natl Acad Sci U S A (2008) 1.28
The 5' end of U2 snRNA is in close proximity to U1 and functional sites of the pre-mRNA in early spliceosomal complexes. Mol Cell (2007) 1.26
Cyclin A/Cdk2 complexes regulate activation of Cdk1 and Cdc25 phosphatases in human cells. Oncogene (2004) 1.24
3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis. Cancer Res (2006) 1.22
Small-molecule inhibition of HIV pre-mRNA splicing as a novel antiretroviral therapy to overcome drug resistance. PLoS Pathog (2007) 1.18
U2 snRNA-protein contacts in purified human 17S U2 snRNPs and in spliceosomal A and B complexes. Mol Cell Biol (2006) 1.18
Stalling of spliceosome assembly at distinct stages by small-molecule inhibitors of protein acetylation and deacetylation. RNA (2008) 1.16
Multiple U2AF65 binding sites within SF3b155: thermodynamic and spectroscopic characterization of protein-protein interactions among pre-mRNA splicing factors. J Mol Biol (2005) 1.10
Biochemical and NMR analyses of an SF3b155-p14-U2AF-RNA interaction network involved in branch point definition during pre-mRNA splicing. RNA (2006) 1.09
Invariant U2 snRNA nucleotides form a stem loop to recognize the intron early in splicing. Mol Cell (2010) 1.05
Insights into branch nucleophile positioning and activation from an orthogonal pre-mRNA splicing system in yeast. Mol Cell (2009) 1.03
Structuring of the 3' splice site by U2AF65. J Biol Chem (2003) 1.02
Association of U2 snRNP with the spliceosomal complex E. Nucleic Acids Res (1997) 1.01
Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF. Cancer Sci (2010) 1.00
Physiological and oncogenic Aurora-A pathway. Int J Biol Sci (2009) 0.97
Protection against retrovirus pathogenesis by SR protein inhibitors. PLoS One (2009) 0.81
Alternative splicing and genome complexity. Nat Genet (2001) 7.30
Nucleosome positioning as a determinant of exon recognition. Nat Struct Mol Biol (2009) 5.14
Optimization of oligonucleotide-based DNA microarrays. Nucleic Acids Res (2002) 3.36
Regulation of Fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Mol Cell (2005) 2.99
Intron removal requires proofreading of U2AF/3' splice site recognition by DEK. Science (2006) 2.52
The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov (2012) 2.51
Regulatory defects in liver and intestine implicate abnormal hepcidin and Cybrd1 expression in mouse hemochromatosis. Nat Genet (2003) 2.43
RBM5/Luca-15/H37 regulates Fas alternative splice site pairing after exon definition. Mol Cell (2008) 2.39
The splicing regulator TIA-1 interacts with U1-C to promote U1 snRNP recruitment to 5' splice sites. EMBO J (2002) 2.33
Building specificity with nonspecific RNA-binding proteins. Nat Struct Mol Biol (2005) 2.31
Splicing regulation at the second catalytic step by Sex-lethal involves 3' splice site recognition by SPF45. Cell (2002) 1.94
Genome-wide analysis of alternative pre-mRNA splicing. J Biol Chem (2007) 1.78
The expanding transcriptome: the genome as the 'Book of Sand'. EMBO J (2006) 1.73
Multi-domain conformational selection underlies pre-mRNA splicing regulation by U2AF. Nature (2011) 1.57
Decrypting the genome's alternative messages. Curr Opin Cell Biol (2009) 1.49
U2AF-homology motif interactions are required for alternative splicing regulation by SPF45. Nat Struct Mol Biol (2007) 1.38
The Ewing sarcoma protein regulates DNA damage-induced alternative splicing. Mol Cell (2011) 1.33
CPEB1 coordinates alternative 3'-UTR formation with translational regulation. Nature (2013) 1.23
Alternative splicing microarrays reveal functional expression of neuron-specific regulators in Hodgkin lymphoma cells. J Biol Chem (2004) 1.22
hnRNP A1 proofreads 3' splice site recognition by U2AF. Mol Cell (2012) 1.19
Two isoforms of the T-cell intracellular antigen 1 (TIA-1) splicing factor display distinct splicing regulation activities. Control of TIA-1 isoform ratio by TIA-1-related protein. J Biol Chem (2007) 1.18
Fas-activated serine/threonine kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate Fas alternative splicing. J Biol Chem (2006) 1.17
Biochemical function of female-lethal (2)D/Wilms' tumor suppressor-1-associated proteins in alternative pre-mRNA splicing. J Biol Chem (2002) 1.11
Diversity of vertebrate splicing factor U2AF35: identification of alternatively spliced U2AF1 mRNAS. J Biol Chem (2004) 1.03
Differential 3' splice site recognition of SMN1 and SMN2 transcripts by U2AF and U2 snRNP. RNA (2009) 0.99
Getting to the heart of a splicing enhancer. Nat Struct Biol (2003) 0.98
Isolated pseudo-RNA-recognition motifs of SR proteins can regulate splicing using a noncanonical mode of RNA recognition. Proc Natl Acad Sci U S A (2013) 0.98
Global analysis of alternative splicing regulation by insulin and wingless signaling in Drosophila cells. Genome Biol (2009) 0.96
U2 small nuclear ribonucleoprotein particle (snRNP) auxiliary factor of 65 kDa, U2AF65, can promote U1 snRNP recruitment to 5' splice sites. Biochem J (2003) 0.95
Distinct regulatory programs establish widespread sex-specific alternative splicing in Drosophila melanogaster. RNA (2011) 0.92
Chromatin's thread to alternative splicing regulation. Chromosoma (2013) 0.91
Regulation of alternative pre-mRNA splicing. Brief Funct Genomic Proteomic (2002) 0.90
A simple principle to explain the evolution of pre-mRNA splicing. Genes Dev (2006) 0.88
Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms. Mol Endocrinol (2009) 0.86
Evolution. Splicing in 4D. Science (2012) 0.84
Strict 3' splice site sequence requirements for U2 snRNP recruitment after U2AF binding underlie a genetic defect leading to autoimmune disease. RNA (2011) 0.82
Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry. Clin Cancer Res (2013) 0.82
In vitro correction of a pseudoexon-generating deep intronic mutation in LGMD2A by antisense oligonucleotides and modified small nuclear RNAs. Hum Mutat (2013) 0.82
RNA processing: Redrawing the map of charted territory. Mol Cell (2009) 0.82
Gene regulation: Breaking the second genetic code. Nature (2010) 0.81
A splicing mastermind for EMT. EMBO J (2010) 0.80
RNAtomy of the Spliceosome's heart. EMBO J (2013) 0.78
Molecular biology: spliceosome meets telomerase. Nature (2008) 0.77
Competition by the masses. Mol Cell (2013) 0.76
Unweaving the meanings of messenger RNA sequences. Mol Cell (2006) 0.75
Powering a two-stroke RNA engine. Nat Struct Mol Biol (2007) 0.75
Corrigendum: Relationship between nucleosome positioning and progesterone-induced alternative splicing in breast cancer cells. RNA (2015) 0.75